Features of the Treatment of Metastatic Cervical Cancer
Abstract
Relevance:
Cervical Cancer (CC) remains one of the most prevalent malignant neoplasms worldwide, accounting for approximately 60–80% of all gynecological cancers and ranking second among malignancies of the female reproductive system after endometrial carcinoma. According to global epidemiological data, CC constitutes nearly one-third of all tumors in women and represents about 16% of malignancies following breast cancer. The highest incidence of CC is observed among socially active women aged 45–55 years. At the same time, analysis of age-specific indicators demonstrates a rising trend in the incidence among younger women of reproductive age, particularly under 40 years, with a peak occurring before the age of 29.
References
1. K.M. Abdulkadyrov, O.A. Rukaeitsy, S.S. Bessmeltsev. Low doses of alpha-interferon препаратов in the treatment of patients with Chronic Myeloid Leukemia. Therapeutic Archive. 2000; Vol. 72, No. 7: 22–27.
2. A.A. Abrarov, R.A. Sabirova, M.A. Kadyrova, D.F. Yunusova. Influence of tocopherol and retinol on certain metabolic parameters in lung tissue. In: Proceedings of the 5th Conference of Biochemists of Central Asia and Kazakhstan. Tashkent, November 12–15, 1991: 265.
3. K.G. Airapetov. Traditional and modified autohemochemotherapy in the комплекс treatment of patients with Non-Hodgkin Lymphoma. Abstract of Candidate of Medical Sciences dissertation. Rostov-on-Don; 2002: 29 p.
4. G.M. Azimova. Causes of occurrence and metastasis of Cervical Cancer. Economics and Society. 2024; No. 4-1 (119).
5. V.Ya. Alexandrov. Cell Reactivity and Proteins. Leningrad: Nauka; 1985.
6. Yu.A. Aitonishkis. Segmentation of neutrophil nuclei: a new perspective on the nature of the phenomenon. Clinical Laboratory Diagnostics. 2006; No. 8: 22–25.
